[EN] SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES AS LIGANDS AT ALPHA 7 NICOTINIC ACETY LCHOLINE RECEPTORS<br/>[FR] DERIVES DE DIAZABICYCLOALCANE SUBSTITUES UTILISES EN TANT QUE LIGANDS AU NIVEAU DES RECEPTEURS ALPHA 7 DE L'ACETYLCHOLINE NICOTINIQUE
申请人:ABBOTT LAB
公开号:WO2005028477A1
公开(公告)日:2005-03-31
Compounds of formula (I) Z-Ar 1 -Ar 2 wherein Z is a diazabicyclic amine, Ar 1 is a 5- or 6-membered aromatic ring, and Ar 2 is selected from the group consisting of an unsubstituted or substituted 5- or 6-membered heteroaryl ring; unsubstituted or substituted bicyclic heteroaryl ring; 3,4-(methylenedioxy)phenyl; carbazolyl; tetrahydrocarbazolyl; naphthyl; and phenyl; wherein the phenyl is substituted with 0, 1, 2, or 3 substituents in the meta- or para-positions. The compounds are useful in treating conditions or disorders prevented by or ameliorated by α7 nAChR ligands. Also disclosed are pharmaceutical compositions comprising compounds of formula (I) and methods for using such compounds and compositions.
化合物的公式(I)为Z-Ar1-Ar2,其中Z是一种二氮杂双环胺,Ar1是一种5-或6-成员的芳香环,而Ar2则选自于未取代或取代的5-或6-成员杂芳基环;未取代或取代的双环杂芳基环;3,4-(亚甲氧基)苯基;咔唑基;四氢咔唑基;萘基;以及苯基;其中苯基在间位或对位上取代有0、1、2或3个取代基。这些化合物在治疗由α7 nAChR配体预防或缓解的疾病或疾病状态中有用。此外,还披露了包含公式(I)化合物的制药组合物以及使用这些化合物和组合物的方法。